Correlation Between Resverlogix Corp and Oncolytics Biotech

Can any of the company-specific risk be diversified away by investing in both Resverlogix Corp and Oncolytics Biotech at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Resverlogix Corp and Oncolytics Biotech into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Resverlogix Corp and Oncolytics Biotech, you can compare the effects of market volatilities on Resverlogix Corp and Oncolytics Biotech and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Resverlogix Corp with a short position of Oncolytics Biotech. Check out your portfolio center. Please also check ongoing floating volatility patterns of Resverlogix Corp and Oncolytics Biotech.

Diversification Opportunities for Resverlogix Corp and Oncolytics Biotech

-0.1

Correlation Coefficient

Resverlogix Corp  Oncolytics Biotech

Good diversification

The 3 months correlation between Resverlogix and Oncolytics is -0.1. Overlapping area represents the amount of risk that can be diversified away by holding Resverlogix Corp and Oncolytics Biotech in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Oncolytics Biotech and Resverlogix Corp is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Resverlogix Corp are associated (or correlated) with Oncolytics Biotech. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Oncolytics Biotech has no effect on the direction of Resverlogix Corp i.e., Resverlogix Corp and Oncolytics Biotech go up and down completely randomly.

Pair Corralation between Resverlogix Corp and Oncolytics Biotech

Assuming the 90 days trading horizon Resverlogix Corp is expected to under-perform the Oncolytics Biotech. In addition to that, Resverlogix Corp is 1.4 times more volatile than Oncolytics Biotech. It trades about -0.03 of its total potential returns per unit of risk. Oncolytics Biotech is currently generating about 0.0 per unit of volatility. If you would invest  138.00  in Oncolytics Biotech on September 4, 2024 and sell it today you would lose (11.00) from holding Oncolytics Biotech or give up 7.97% of portfolio value over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Insignificant
Accuracy	98.44%
Values	Daily Returns

Resverlogix Corp  vs.  Oncolytics Biotech

Resverlogix Corp

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Resverlogix Corp has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of latest unfluctuating performance, the Stock's basic indicators remain healthy and the recent disarray on Wall Street may also be a sign of long period gains for the firm investors.

Oncolytics Biotech

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Oncolytics Biotech has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of very healthy fundamental indicators, Oncolytics Biotech is not utilizing all of its potentials. The recent stock price disarray, may contribute to short-term losses for the investors.

Pair Trading with Resverlogix Corp and Oncolytics Biotech

The main advantage of trading using opposite Resverlogix Corp and Oncolytics Biotech positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Resverlogix Corp position performs unexpectedly, Oncolytics Biotech can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Oncolytics Biotech will offset losses from the drop in Oncolytics Biotech's long position.

The idea behind Resverlogix Corp and Oncolytics Biotech pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Diagnostics module to use generated alerts and portfolio events aggregator to diagnose current holdings.